ERBB2 and cancer: Furthermore, numerous studies have identified additional biomarkers, such as human epidermal growth factor receptor 2 (HER2) [101], estrogen receptors [102], and folate receptors [103], which serve as characteristic markers for CTCs across various types of cancers.